Navigation Links
Essilor : Nomination of Hubert Sagnieres

CHARENTON-LE-PONT, France, August 28 /PRNewswire-FirstCall/ --

- Hubert Sagnieres Appointed Chief Operating Officer of Essilor

The Board of Directors of Essilor International today appointed Hubert Sagnieres as Chief Operating Officer, to serve alongside Xavier Fontanet, Chief Executive Officer, and Philippe Alfroid, Chief Operating Officer.

A graduate of Ecole Centrale in Lille and holder of an MBA from Insead, Hubert Sagnieres joined Essilor in 1989 as President of International Marketing. He was appointed President of Essilor Canada in 1991, and President of Essilor Laboratories of America in 1997, then President of Essilor of America. Since 2006, he has been President of the North American and Europe Regions, a position that he will continue to hold in addition to his new responsibilities.

Hubert Sagnieres was also elected to the Essilor Board of Directors at the Shareholders' Meeting on May 14, 2008.

Essilor International is the world leader in ophthalmic optical products, offering a wide range of lenses under the flagship Varilux(R), Crizal(R), Essilor(R) and Definity(R) brands to correct myopia, hyperopia, presbyopia and astigmatism. Essilor operates worldwide through 15 production sites, 270 lens finishing laboratories and local distribution networks.

The Essilor share trades on the Euronext Paris market and is included in the CAC 40 index.

Codes and symbols: ISIN: FR 0000121667; Reuters: ESSI.PA; Bloomberg: EF.FP.

Investor Relations and Financial Communications

Veronique Gillet - Sebastien Leroy

Phone: +33(0)1-49-77-42-16

SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Essilors 2007 Third-Quarter Report
2. Essilor Cancels 700,000 Shares
3. Essilor: New Acquisitions in the United States and Brazil
5. GBC Seeks Nominations for Regions Third Annual Bioscience Awards
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015  Northwest Biotherapeutics (NASDAQ: ... developing DCVax® personalized immune therapies for solid tumor cancers, ... an additional independent director, and the Company welcomes ... allegations in a recent anonymous internet report on NW ... initiatives. Linda Powers stated, "We agree ...
(Date:11/27/2015)... PA (PRWEB) , ... November 27, 2015 , ... ... Technical Program that includes over 2,000 technical presentations offered in symposia, oral ... chemistry and applied spectroscopy, covers a wide range of applications such as, but ...
(Date:11/25/2015)...  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that ... plan (Rights Plan) in an effort to preserve the ... Section 382 of the Internal Revenue Code (Code). ... of its NOLs could be substantially limited if the ... 382 of the Code. In general, an ownership change ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
Breaking Biology Technology:
(Date:11/4/2015)... --> --> ... Transparency Market Research "Home Security Solutions Market - Global Industry ... 2022", the global home security solutions market is expected to reach ... market is estimated to expand at a CAGR of ... Rising security needs among customers at homes, the emergence ...
(Date:10/29/2015)... Va. , Oct. 29, 2015 Daon, ... today that it has released a new version of ... customers in North America have ... IdentityX v4.0 also includes a FIDO UAF certified ... are already preparing to activate FIDO features. These customers ...
(Date:10/29/2015)... NEW YORK , Oct. 29, 2015 /PRNewswire/ ... wearable technology, announced a partnership with 2XU, a ... accessories, to deliver a smart hat with advanced ... runners and other athletes to monitor key biometrics ... of the strategic partnership, the two companies will bring ...
Breaking Biology News(10 mins):